Stephan Timo Ledderose

7PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersHaematological tumoursBasic pharmacologyMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 23, 2026
Ectonucleotidases CD39 and CD73 expression levels are independent and inverse predictors of survival in muscle-invasive bladder cancer.

|Mar 04, 2026
High-Grade Urothelial Carcinoma Arising From a Ureteral Diverticulum: A Rare Case Report.

Iason Papadopoulos, Stephan Ledderose, Benedikt Ebner

|Dec 31, 2025
Pine-Extracted Phytosterol β-Sitosterol (APOPROSTAT® Forte) Inhibits Both Human Prostate Smooth Muscle Contraction and Prostate Stromal Cell Growth, Without Cytotoxic Effects: A Mechanistic Link to Clinical Efficacy in LUTS/BPH.

Alexander Tamalunas, Felix Schierholz, Henrik Poth

|Aug 14, 2025
Adverse Pathology After Radical Prostatectomy in Low- and Intermediate-Risk Prostate Cancer: A Propensity Score-Matched Analysis of Long-Term Health-Related Quality of Life.

Michael Chaloupka, Alexander Buchner, Marc Kidess

|Jul 12, 2025
Expression Profiles of Co-Inhibitory Receptors in Non-Urothelial Bladder Cancer: Preclinical Evidence for the Next Generation of Immune Checkpoint Inhibitors.

Severin Rodler, Stephan T Ledderose, Raphaela Waidelich

|Apr 18, 2025
Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor-Induced Colitis Compared with Ulcerative Colitis.

Giulia Pesch, Ignazio Piseddu, Jan Gaertig

Pageof 2

Frequent Collaborators

3 joint publications

Christian Georg Stief

1 joint publications

Giulia Pesch

1 joint publications

Ignazio Piseddu

1 joint publications

Jan Gaertig